Oxford University, which developed the vaccine after reports emerged that some people with the AstraZeneca vaccine had died, shared the results of the research with the public.
Details of the corona virus vaccine developed by AstraZeneca and Oxford University have been shared with the public.
According to U.S. research, the vaccine developed has a 79 percent effect on stopping symptomatic diseases.
On the other hand, those who received the vaccine were 100 percent affected by the rate of being admitted to intensive care or severely ill.
“As a result of the vaccine research involving more than 32,000 volunteers from different age groups in the U.S., Chile and Peru, we found that this vaccine was protective and highly effective,” the University of Oxford said in a statement.
The corona virus vaccine developed by Oxford University and AstraZeneca has both created a diplomatic crisis and caused health tensions in recent weeks.
An investigation was launched after the deaths of people with the AstraZeneca vaccine in several countries, especially Denmark, and it was announced that they had clotted in their blood. Many European countries have stopped using the AstraZeneca vaccine.
The World Health Organization announced that the benefits of getting the AstraZeneca vaccine outstretched and said there was no link to the deaths with the vaccine.